- Atlas
- Natural Sciences
- Medical Genetics
Medical Genetics
Medical genetics is the branch of medicine that deals with inherited disease: how changes in DNA are passed down families, how they produce illness, and how clinicians can diagnose, predict, prevent, and sometimes treat them.
11 frameworks, from 1900 to today · Genomics · Natural Sciences
- Mendelian Pedigree Analysis 1900-Present
- Inborn Errors of Metabolism 1902-1960
- Cytogenetics 1956-Present
- Pharmacogenomics 1960-Present
- Clinical Nosology and the Gene Catalogue 1966-Present
- Genetic counseling 1970-Present
- Predictive and Prenatal Testing 1970-Present
- Positional Cloning 1980-2005
- Cancer Genetics 1990-Present
- Clinical Genomics and Variant Interpretation 2005-Present
- Complex Disease and Polygenic Genetics 2005-Present
Overview
Medical genetics is the branch of medicine that deals with inherited disease: how changes in DNA are passed down families, how they produce illness, and how clinicians can diagnose, predict, prevent, and sometimes treat them1. Its practitioners are physicians and counsellors who read family trees, order tests, and interpret genomes for patients1. What is at stake is concrete: whether a family learns that a child will develop a fatal disorder, whether a cancer can be caught early, whether a drug will work or poison. The field's history is the story of how inherited disease moved from something observed in families to something read in molecules—and of the tools that made that move possible.
Cataloguing the Inborn Errors of Metabolism
The scientific study of inherited disease begins with Archibald Garrod, a London physician who in 1902 described alkaptonuria, a rare condition in which urine turns black on standing. Garrod noticed that the condition ran in families, often among the children of first cousins, and reasoned that it behaved like a recessive trait. He proposed that patients lacked an enzyme needed to break down a normal metabolic intermediate, and in a series of lectures published as Inborn Errors of Metabolism (1909) he extended the idea to albinism, cystinuria, and pentosuria. Garrod's insight—that a gene specifies an enzyme and a defective gene produces a metabolic block—was decades ahead of its proof, but it established the founding logic of the field: inherited disease is a chemical defect with a family pattern.
Cytogenetics: Counting and Reading Chromosomes
For the first half of the twentieth century, human genetics was largely a science of pedigrees, because human chromosomes were hard to see. That changed in 1956, when Joe Hin Tjio and Albert Levan, working in Lund, reported that human cells contain 46 chromosomes—correcting a long-standing belief in 48. The technique that made this possible, treating cells so chromosomes spread and stain distinctly, opened cytogenetics: the study of chromosomes under the microscope.
The payoff came fast. In 1959, Jérôme Lejeune described an extra copy of chromosome 21 in Down syndrome, the first human disorder tied to a visible chromosomal abnormality. In the same year, abnormalities of the sex chromosomes were linked to Turner and Klinefelter syndromes. Later refinements—banding techniques in the late 1960s that gave each chromosome a recognizable stripe pattern, and in the 1980s fluorescence in situ hybridization (FISH), which lit up specific DNA sequences on chromosomes—turned cytogenetics into a routine diagnostic service. It could detect whole-chromosome errors, deletions, and translocations, but not the single-letter changes that cause most Mendelian disease.
Pedigrees, Nosology, and the Gene Catalogue
Alongside cytogenetics, clinical geneticists built a discipline of careful family study. Mendelian pedigree analysis—drawing family trees and testing whether a trait's transmission fits dominant, recessive, or sex-linked patterns—became the field's core reasoning tool. It let clinicians predict recurrence risks and distinguish inherited from sporadic disease. Victor McKusick at Johns Hopkins began in the 1950s to compile inherited conditions systematically, publishing Mendelian Inheritance in Man in 1966; the catalogue, later online as OMIM, grew into the field's reference map of thousands of disorders. This nosology—the systematic classification of disease—mattered because a named, well-characterized syndrome could be recognized in the next family and eventually traced to a gene.
Molecular Cloning and the Hunt for Genes
The decisive turn came with recombinant DNA in the 1970s. Restriction enzymes, which cut DNA at specific sequences, and molecular cloning, which copies a DNA fragment in bacteria, gave researchers the ability to isolate and study individual human genes2. The first disease gene found this way was for sickle-cell anemia: in 1978, using a globin gene probe, researchers showed that the causative mutation abolished a restriction site, a direct DNA diagnosis of a Mendelian disorder.
Finding genes whose protein product was unknown required a different strategy. Positional cloning—locating a gene purely by its chromosomal position, without knowing what it made—was the answer3. Linkage mapping first placed a disease locus relative to known markers in families; then chromosome walking closed in on the gene3. The method scored its landmark success in 1987, when Louis Kunkel's group cloned the gene for Duchenne muscular dystrophy, and again in 1989 with the cystic fibrosis gene, found by a multi-group effort led by Lap-Chee Tsui and Francis Collins. These were hard, slow campaigns, but they proved that any Mendelian disease gene could in principle be found.
Predictive and Prenatal Testing
Once a gene and its mutations were known, testing became possible. Carrier testing could identify unaffected people who carried one copy of a recessive mutation. Prenatal diagnosis, using fetal cells from amniocentesis or chorionic villus sampling, could tell parents whether a fetus was affected. Predictive testing could tell a healthy adult whether they carried a mutation that would later cause disease—most famously for Huntington's disease, whose gene was mapped in 1983 and cloned in 1993. These tests raised questions no laboratory could answer alone: whether to test, whom to tell, and what a result meant for relatives. That is where genetic counselling emerged as a clinical profession, distinct from laboratory genetics, concerned with explaining risk, supporting decisions, and protecting confidentiality. Its professional bodies and training programs took shape from the 1970s onward.
Cancer Genetics
Cancer genetics grew from two directions. Clinically, physicians noticed families with striking clusters of early-onset breast, ovarian, and colon cancer, and pedigree analysis suggested inherited susceptibility. Positional cloning identified the genes: APC for familial adenomatous polyposis in 1991, BRCA1 in 1994 and BRCA2 in 1995 for hereditary breast and ovarian cancer. Testing for these mutations let carriers choose intensified screening or preventive surgery. In parallel, tumor genetics showed that cancers arise through accumulated mutations in oncogenes and tumor-suppressor genes, so that the same molecular logic explained both inherited risk and sporadic tumors.
Pharmacogenomics
A separate thread asked why the same drug helps one patient and harms another. The field of pharmacogenetics—later pharmacogenomics when it scaled to whole-genome methods—traced drug responses to inherited variation in enzymes that metabolize drugs. The classic case is the gene CYP2D6, whose variants make some people poor metabolizers and others ultrarapid, changing how they handle many common medicines. The aim, still only partly realized in the clinic, is to choose drugs and doses by genotype rather than by trial and error.
The Genomic Era and Variant Interpretation
The Human Genome Project, completed in draft in 2001 and to high accuracy in 2003, changed the economics of gene discovery. Massively parallel sequencing, introduced around 2005, could read millions of DNA fragments at once, and by the 2010s whole-exome sequencing (reading just the protein-coding portion of the genome) and whole-genome sequencing became affordable enough for diagnosis. Clinical genomics shifted the question from "can we find the gene?" to "what does this variant mean?" Variant interpretation became a discipline of its own: comparing a patient's variant against population databases, family segregation, and functional evidence, and classifying it on a scale from benign to pathogenic. The field's professional guidelines for this classification, issued by the American College of Medical Genetics and Genomics and updated with the Association for Molecular Pathology, standardized what had been ad hoc judgment.
Complex Disease and Polygenic Genetics
Most common disease—diabetes, heart disease, most cancers—does not follow Mendelian patterns. The tools for this were genome-wide association studies (GWAS), which from 2005 onward compared hundreds of thousands of common variants between cases and controls to find statistical associations. GWAS revealed that common diseases are influenced by many variants of small effect, and polygenic risk scores now sum those effects into a single number4. How useful such scores are in the clinic, and how they perform across ancestries, remains an open and actively debated question.
Where the Field Stands
Today medical genetics runs on clinical genome and exome sequencing, chromosomal microarray (a higher-resolution successor to karyotyping), and increasingly on rapid sequencing in newborn and critical-care settings. Genetic counselling is embedded in cancer, prenatal, cardiac, and pediatric care. The unresolved questions are real: how to interpret the thousands of variants of uncertain significance that sequencing turns up, how to make polygenic risk useful without widening health disparities, and how to deliver genomic medicine equitably beyond the well-resourced centers where it was built.
References
- Medical genetics (introduction, Scope, Genetic counseling), Wikipedia
- Molecular cloning (introduction, History), Wikipedia
- Genetic screen (Positional cloning), Wikipedia
- Polygenic score, Wikipedia
The frameworks of Medical Genetics
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1900-Present
- 1902-1960
Inborn Errors of Metabolism
How do defective genes cause metabolic disease?
- 1956-Present
- 1960-Present
- 1966-Present
Clinical Nosology and the Gene Catalogue
How should inherited diseases be classified?
- 1970-Present
- 1970-Present
Predictive and Prenatal Testing
Can we know if a person will develop a genetic disease?
- 1980-2005
Positional Cloning
How can we find a disease gene without knowing its product?
- 1990-Present
- 2005-Present
Clinical Genomics and Variant Interpretation
What does a variant in a patient's genome mean?
- 2005-Present
Complex Disease and Polygenic Genetics
How do many genes together influence common disease?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Inborn Errors of Metabolism influenced by Mendelian Pedigree Analysis
Garrod used Mendelian pedigree patterns—recessive transmission and consanguinity—to argue that alkaptonuria was an inherited chemical defect, founding the inborn errors concept.
Carried by Archibald Garrod.
Clinical Nosology and the Gene Catalogue grew out of Mendelian Pedigree Analysis
McKusick's Mendelian Inheritance in Man systematized the pedigree-based classification of single-gene disorders into a catalogue that became the field's reference nosology.
Carried by Victor McKusick; Mendelian Inheritance in Man (1966).
Cancer Genetics influenced by Positional Cloning
Positional cloning was the method used to identify the inherited cancer genes APC in 1991 and BRCA1 in 1994, establishing cancer genetics.
Carried by Mary-Claire King; BRCA1 (1994).
Genetic counseling influenced by Mendelian Pedigree Analysis
Genetic counselling took the recurrence risks calculated from pedigree analysis as the basis for explaining inheritance to families.
Positional Cloning influenced by Mendelian Pedigree Analysis
Positional cloning began with linkage mapping in pedigrees to place a disease locus relative to markers before cloning the gene.
Predictive and Prenatal Testing influenced by Inborn Errors of Metabolism
The biochemical understanding of inborn errors provided the metabolic assays used for carrier detection and prenatal diagnosis of these disorders.
Predictive and Prenatal Testing influenced by Cytogenetics
Cytogenetic methods such as karyotyping and later FISH enabled prenatal diagnosis of chromosomal abnormalities from fetal cells.
Clinical Genomics and Variant Interpretation replaced Cytogenetics
Chromosomal microarray, a higher-resolution successor to karyotyping, replaced standard cytogenetics for detecting submicroscopic deletions and duplications in clinical genomics.
Clinical Genomics and Variant Interpretation influenced by Pharmacogenomics
Pharmacogenomics became part of clinical genomics as variant interpretation extended to genes such as CYP2D6 that affect drug response.
Clinical Genomics and Variant Interpretation influenced by Clinical Nosology and the Gene Catalogue
The gene catalogue and clinical nosology provided the reference list of disease genes and phenotypes against which genomic variants are interpreted.
Carried by Online Mendelian Inheritance in Man.
Clinical Genomics and Variant Interpretation influenced by Predictive and Prenatal Testing
Prenatal and predictive testing created the demand for interpreting individual genomic variants, which clinical genomics scaled to exome and genome sequencing.
Clinical Genomics and Variant Interpretation replaced Positional Cloning
Massively parallel sequencing replaced positional cloning as the way to find disease genes, shifting the task from gene discovery to variant interpretation.
Clinical Genomics and Variant Interpretation influenced by Cancer Genetics
Cancer genetics provided the clinical models and gene panels that clinical genomics adopted for hereditary cancer risk assessment.
Cancer Genetics influenced by Cytogenetics
Cytogenetic detection of chromosomal translocations and deletions in tumors contributed to the understanding of cancer genetics.
Complex Disease and Polygenic Genetics influenced by Clinical Nosology and the Gene Catalogue
Clinical nosology supplied the disease definitions and phenotype classifications used to build case groups in genome-wide association studies.
Beyond the field
Where Medical Genetics's ideas came from in other fields, and what they led to there: the strongest 12 of 50 links.
Mendelian Pedigree Analysis influenced Epilepsy Genetics in Epilepsy
Mendelian pedigree analysis, established after the rediscovery of Mendel and applied to human disease, was the framework used to trace epilepsy and its EEG traits through families. Epilepsy genetics began as Mendelian pedigree analysis of affected kindreds.
Carried by William Bateson; William Lennox.
Mendelian Pedigree Analysis led to Segregation and linkage analysis in Genetic Epidemiology
Human segregation and linkage analysis grew directly out of Mendelian pedigree analysis, extending simple pedigree tracing to statistical likelihood on family data. The methods of pedigree analysis were formalised into segregation and linkage tests.
Carried by Newton Morton.
Inborn Errors of Metabolism influenced by Mendelian inheritance in Genetics
Garrod's inborn errors concept rested on Mendelian segregation: he treated the metabolic defect as a recessive unit factor transmitted in families. The Mendelian framework gave the disease its hereditary mechanism.
Carried by Archibald Garrod.
Inborn Errors of Metabolism influenced by Mendelian inheritance in Biology
Garrod interpreted alkaptonuria as a recessive Mendelian factor, explicitly drawing on the rediscovered Mendelian doctrine to explain familial recurrence of a metabolic defect. Mendelian inheritance supplied the conceptual frame that made an inherited enzyme deficiency conceivable.
Carried by Archibald Garrod; William Bateson.
Cytogenetics influenced Molecular and cytogenetic hematology in Hematology
General cytogenetics, especially the development of chromosome banding and the Philadelphia chromosome finding, provided the techniques and concepts that hematology adopted for leukemia diagnosis.
Carried by Peter Nowell; David Hungerford.
Cytogenetics influenced by Cytology in Cell Biology
Cytology supplied the staining, squash and microscopy techniques and the chromosome concept on which clinical cytogenetics depended. The identification of the correct human chromosome number in 1956 came directly from cytological methods refined over the preceding decades.
Carried by Joe Hin Tjio; Albert Levan.
Pharmacogenomics grew out of Classical Pharmacogenetics in Pharmacogenomics
Pharmacogenomics grew directly out of classical pharmacogenetics: the study of inherited variation in drug response was extended from single-gene enzyme polymorphisms to genome-wide variation as sequencing and genotyping scaled up. The questions and clinical aims of pharmacogenetics carried over into the renamed field.
Carried by Friedrich Vogel; Arno Motulsky.
Predictive and Prenatal Testing led to Preimplantation Genetic Testing in Reproductive Medicine
Predictive and prenatal testing, with its diagnostic categories and genetic test methods, is the direct ancestor of preimplantation genetic testing, which moved those tests to the embryo stage before implantation.
Predictive and Prenatal Testing influenced Population-Based Prenatal Screening in Maternal Fetal Medicine
Predictive and prenatal testing in medical genetics, including amniocentesis and biochemical marker assays, provided the tests and risk-calculation concepts that population-based prenatal screening programs adopted.
Positional Cloning influenced by Molecular cloning in Microbial Genetics
Molecular cloning techniques, including recombinant DNA methods and cloning vectors developed in the 1970s, gave positional cloning its final step: isolating and characterising the candidate gene once its position was known. The name positional cloning itself refers to this combination of mapping with molecular cloning.
Carried by Stanley Cohen; Herbert Boyer.
Positional Cloning influenced by Genetic mapping and linkage analysis in Genetics
Positional cloning depends on genetic linkage mapping to localise a disease gene to a chromosomal region before the gene itself is isolated. Linkage analysis in families, established by Morgan and refined by Morton and others, supplied the mapping step that positional cloning builds on.
Carried by David Botstein; Ray White.
Positional Cloning influenced by Segregation and linkage analysis in Genetic Epidemiology
Segregation and linkage analysis in genetic epidemiology provided the statistical methods and family data used to map disease loci, the first step of positional cloning. The lod-score approach and pedigree analysis were taken up directly by positional cloning projects.
Carried by Newton Morton.

Medical Genetics is a planet in Nousfarer
Its city has a tower for each of these 11 frameworks. Land, walk in, and climb one concept at a time.
Land on Medical GeneticsRelated fields
Fields its ideas are linked to
- Genetics 10 links
- Genetic Epidemiology 7 links
- Molecular Biology 5 links
- Genomics 4 links
- Animal Genetics 3 links
- Pharmacogenomics 2 links
- Maternal Fetal Medicine 2 links
- Biology 1 link
- Cell Biology 1 link
- Endocrinology And Diabetes 1 link
- Hematology 1 link
- Clinical Decision Science 1 link
More in Genomics
- Bioinformatics
- Comparative Genomics
- Epigenetics
- Functional Genomics
- Genomics
- Population Genetics
- Regulatory Genomics
- Single Cell Genomics
- Transcriptomics
See where Medical Genetics sits on the Map of Human Knowledge